{'fraction_non_alphanumeric': 0.03678474114441417, 'fraction_numerical': 0.02997275204359673, 'mean_word_length': 5.045267489711934, 'pattern_counts': {'":': 0, '<': 3, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effects of Bradykinin on Inducible Sustained Ventricular Tachycardia Two Weeks After Myocardial Infarction in Pigs

Summary: We studied the in vivo effect of bradykinin infusion on inducible sustained ventricular tachycardia (VT) 2 weeks after myocardial infarction in pigs, based on the assumption that the antiarrhythmic effect of angiotensin-converting enzyme (ACE) inhibitors may, apart from their angiotensin-II lowering effect, also be due to elevation of endogenous bradykinin levels. Of the six pigs with inducible VT in the control state, four were noninducible during subsequent bradykinin infusion (p < 0.05). The ventricular effective refractory period (VERP) did not change during bradykinin infusion (from 237 × 37 to 239 × 42 ms), nor did intraventricular conduction change (filtered QRS duration was 45 × 17 ms before and 43 × 19 ms during infusion). Bradykinin caused both a significant systolic blood pressure (SBP) decrease (from 79 × 14 to 49 × 4 mm Hg, p < 0.001) and diastolic BP (DBP) decrease (from 41 × 10 to 27 × 4 mm Hg, p < 0.01). In conclusion, exogenous bradykinin reduced the inducibility of sustained VT 2 weeks after myocardial infarction. Because refractory periods or conduction velocity were not affected, the mechanism of action might be associated with the BP decrease, which can decrease wall stress. The previously reported antiarrhythmic effect of ACE inhibitors may he due in part to elevation of endogenous bradykinin levels.